A048410 Stock Overview
Operates as a biotechnology company. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Hyundai Bioscience Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩14,490.00 |
| 52 Week High | ₩30,750.00 |
| 52 Week Low | ₩13,200.00 |
| Beta | 1.03 |
| 11 Month Change | -15.31% |
| 3 Month Change | -32.76% |
| 1 Year Change | -51.13% |
| 33 Year Change | -53.11% |
| 5 Year Change | 1.33% |
| Change since IPO | 24.91% |
Recent News & Updates
Recent updates
Is Hyundai Bioscience (KOSDAQ:048410) A Risky Investment?
Nov 12
The Trends At Hyundai Bioscience (KOSDAQ:048410) That You Should Know About
Mar 14Is Hyundai Bioscience (KOSDAQ:048410) Using Too Much Debt?
Feb 07
Imagine Holding Hyundai Bioscience (KOSDAQ:048410) Shares While The Price Zoomed 439% Higher
Jan 03The Trends At Hyundai Bioscience (KOSDAQ:048410) That You Should Know About
Nov 29Shareholder Returns
| A048410 | KR Personal Products | KR Market | |
|---|---|---|---|
| 7D | 2.4% | -0.4% | 2.5% |
| 1Y | -51.1% | -11.3% | -1.1% |
Return vs Industry: A048410 underperformed the KR Personal Products industry which returned -11.3% over the past year.
Return vs Market: A048410 underperformed the KR Market which returned -1.1% over the past year.
Price Volatility
| A048410 volatility | |
|---|---|
| A048410 Average Weekly Movement | 7.7% |
| Personal Products Industry Average Movement | 6.5% |
| Market Average Movement | 5.7% |
| 10% most volatile stocks in KR Market | 11.6% |
| 10% least volatile stocks in KR Market | 2.7% |
Stable Share Price: A048410 has not had significant price volatility in the past 3 months compared to the KR market.
Volatility Over Time: A048410's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2000 | n/a | Jong-Won Choi | www.hyundaibioscience.com |
Hyundai Bioscience Co., Ltd. operates as a biotechnology company. The company provides Vitabrid C12, a vitamin C product that delivers active vitamin C into the skin. It develops Polytaxel, a drug for pancreatic cancer and solid tumors; and CP-COV03 drug for Covid 19.
Hyundai Bioscience Co., Ltd. Fundamentals Summary
| A048410 fundamental statistics | |
|---|---|
| Market cap | ₩576.98b |
| Earnings (TTM) | -₩10.44b |
| Revenue (TTM) | ₩15.82b |
36.5x
P/S Ratio-55.3x
P/E RatioIs A048410 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A048410 income statement (TTM) | |
|---|---|
| Revenue | ₩15.82b |
| Cost of Revenue | ₩3.81b |
| Gross Profit | ₩12.01b |
| Other Expenses | ₩22.45b |
| Earnings | -₩10.44b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -262.18 |
| Gross Margin | 75.90% |
| Net Profit Margin | -66.00% |
| Debt/Equity Ratio | 57.6% |
How did A048410 perform over the long term?
See historical performance and comparison